Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€4.56

€4.56

1.320%
0.06
1.320%
-
 
19.09.24 / Tradegate WKN: A0BL84 / Name: Vita 34 / Stock / Healthcare Providers & Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Financial data and news for Vita 34

sharewise wants to provide you with the best news and tools for Vita 34, so we directly link to the best financial data sources.

News

EQS-News: Vita 34 continues positive trend in the first half of 2024 and once again significantly increases operating cash flow
EQS-News: Vita 34 continues positive trend in the first half of 2024 and once again significantly increases operating cash flow
EQS-News: Vita 34 continues positive trend in the first half of 2024 and once again significantly increases operating cash flow
EQS-Adhoc: Subsidiaries of Vita 34 reach agreement with US licensor
EQS-Adhoc: Subsidiaries of Vita 34 reach agreement with US licensor
EQS-Adhoc: Subsidiaries of Vita 34 reach agreement with US licensor
EQS-News: Thomas Pfaadt appointed as new Chief Financial Officer of Vita 34 AG
EQS-News: Thomas Pfaadt appointed as new Chief Financial Officer of Vita 34 AG
EQS-News: Thomas Pfaadt appointed as new Chief Financial Officer of Vita 34 AG
EQS-News: Vita 34 significantly increases earnings and operating cash flow in the first quarter
EQS-News: Vita 34 significantly increases earnings and operating cash flow in the first quarter
EQS-News: Vita 34 significantly increases earnings and operating cash flow in the first quarter
EQS-News: Vita 34 returns to growth path in 2023
EQS-News: Vita 34 returns to growth path in 2023
EQS-News: Vita 34 returns to growth path in 2023
EQS-Adhoc: Vita 34 closes 2023 with significantly better results than expected based on preliminary figures
EQS-Adhoc: Vita 34 closes 2023 with significantly better results than expected based on preliminary figures
EQS-Adhoc: Vita 34 closes 2023 with significantly better results than expected based on preliminary figures